{
  "protocolSection": {
    "identificationModule": {
      "nctId": "NCT02132247",
      "orgStudyIdInfo": {
        "id": "IBSA-FLE-2013-01",
        "type": null,
        "link": null
      },
      "secondaryIdInfos": [],
      "organization": {
        "fullName": "IBSA Institut Biochimique SA",
        "class": "INDUSTRY"
      },
      "briefTitle": "Safety and Efficacy of the FLECTOR (Diclofenac Epolamine) Topical System in Children with Minor Soft Tissue Injuries",
      "officialTitle": "Safety and Efficacy of the FLECTOR (Diclofenac Epolamine) Topical System in Children with Minor Soft Tissue Injuries: A Phase IV Non-randomized Clinical Trial",
      "acronym": null
    },
    "descriptionModule": null,
    "conditionsModule": null,
    "designModule": null,
    "armsInterventionsModule": null,
    "outcomesModule": null,
    "eligibilityModule": {
      "eligibilityCriteria": "Inclusion Criteria:\n- Children aged 6–16 years\n- Clinically significant minor soft tissue injury sustained within the preceding 96 hours\n- Spontaneous pain of at least moderate severity, defined as a score of ≥3 on the 6-point Wong-Baker FACES® Pain Rating Scale\n- Post-menarche girls required to have a negative pregnancy test\n- Informed consent required for all participants and/or their legal guardians\n\nExclusion Criteria:\n- Injury was midline or major\n- Injury involved the spine, digits, or hands\n- Open skin lesions within the injured area\n- Severe cardiac, renal, or hepatic impairment\n- Use of a long-acting NSAID since sustaining the injury\n- Use of topical medication within the past 48 hours",
      "healthyVolunteers": false,
      "sex": "ALL",
      "minimumAge": "6 Years",
      "maximumAge": "16 Years",
      "stdAges": [
        "CHILD"
      ],
      "studyPopulation": null,
      "samplingMethod": null
    }
  }
}